Skip to main content
. 2022 Jan 10;14(2):325. doi: 10.3390/cancers14020325

Table 5.

Lymphocyte subpopulations in peripheral blood at SARS-CoV-2 vaccination by serological conversion after vaccination.

Lymphocyte Subpopulations All Pts p Pts after alloHCT
Pts with Seroconversion
N
Pts without Seroconversion
N
Pts with Seroconversion
N
Pts without Seroconversion
N
p
77 7 53 6
Median (range) of lymphocyte count in blood (G/L) 1.36 (0.33–6.67) 1.13 (0.79–3.77) 0.69 1.38 (0.33–6.67) 1.32 (0.79–3.77) 0.89
Median (range) of B-cell count in blood (G/L) 0.21 (0.00–1.11) 0.01 (0.00–0.35) 0.014 0.22 (0.0–1.11) 0.07 (0.0–0.35) 0.038
Median (range) percentage of B cells in blood (%) 13.5 (0.1–41.0) 1.5 (0.0–10.0) <0.001 14.5 (1.40–41.0) 4.50 (0.04–10.00) <.001
Median (range) of T-cell count in blood (G/L) 0.89 (0.23–5.86) 1.08 (0.42–2.90) 0.66 0.87 (0.23–5.86) 1.03 (0.42–2.89) 0.83
Median (range) percentage of T cells in blood (%) 66.9 (23.0–95.9) 76.8 (53.3–95.9) 0.098 65.9 (23.0–95.9) 23.95 (13.90–38.50) 0.27
Median (range) of CD4+ T-cell count in blood (G/L) 0.23 (0.04–0.73) 0.21 (0.1–0.64) 0.92 0.22 (0.04–0.73) 0.21 (0.09–0.64) 0.64
Median (range) percentage of CD4+ T cells in blood (%) 28.0 (9.4–70.1) 25.8 (13.9–38.5) 0.76 28.0 (9.4–70.1) 23.95 (13.9–38.5) 0.57
Median (range) of CD8+ T-cell count in blood (G/L) 0.61 (0.11–5.34) 0.64 (0.24–2.21) 0.80 0.57 (0.11–5.34) 0.64 (0.24–2.21) 0.72
Median (range) percentage of CD8+ T cells in blood (%) 70.4 (27.9- 91.1) 64.1 (56.8–82.3) 0.66 70.3 (27.9–91.1) 70.2 (56.8–82.3) 0.98
Median (range) of NK-cell count in blood (G/L) 0.13 (0.02–0.71) 0.15 (0.04–0.37) 0.50 0.12 (0.02–0.71) 0.17 (0.12–0.37) 0.10
Median (range) percentage of NK cells in blood (%) 15.2 (2.1–54.3) 12.8 (3.9–45.8) 0.99 13.9 (2.1–54.3) 18.7 (8.1–45.8) 0.47

Pts, patients; HCT, hematopoietic stem cell transplantation; alloHCT, allogeneic hematopoietic stem cell transplantation; IS, immunosuppressive; TCI, Transplant Conditioning Intensity; CNI, calcineurin inhibitor; NA, not applicable.